Literature DB >> 15036206

Tau protein and neurodegeneration.

Michel Goedert1.   

Abstract

Tau protein is the major component of the intracellular filamentous deposits that define a number of neurodegenerative diseases. They include the largely sporadic Alzheimer's disease, progressive supranuclear palsy (PSP), corticobasal degeneration (CBD), Pick's disease (PiD), argyrophilic grain disease, as well as the inherited frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17). The identification of mutations in Tau as the cause of FTDP-17 established that dysfunction or misregulation of tau protein is sufficient to cause neurodegeneration and dementia. At an experimental level, the new understanding is leading to the development of good transgenic animal models of the tauopathies.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15036206     DOI: 10.1016/j.semcdb.2003.12.015

Source DB:  PubMed          Journal:  Semin Cell Dev Biol        ISSN: 1084-9521            Impact factor:   7.727


  56 in total

1.  Tuning microtubule-based transport through filamentous MAPs: the problem of dynein.

Authors:  Michael Vershinin; Jing Xu; David S Razafsky; Stephen J King; Steven P Gross
Journal:  Traffic       Date:  2008-03-28       Impact factor: 6.215

2.  Combinatorial Tau pseudophosphorylation: markedly different regulatory effects on microtubule assembly and dynamic instability than the sum of the individual parts.

Authors:  Erkan Kiris; Donovan Ventimiglia; Mehmet E Sargin; Michelle R Gaylord; Alphan Altinok; Kenneth Rose; B S Manjunath; Mary Ann Jordan; Leslie Wilson; Stuart C Feinstein
Journal:  J Biol Chem       Date:  2011-02-02       Impact factor: 5.157

3.  Inositol 1,4,5-trisphosphate 3-kinase A is a novel microtubule-associated protein: PKA-dependent phosphoregulation of microtubule binding affinity.

Authors:  Dongmin Lee; Hyun Woo Lee; Soontaek Hong; Byung-Il Choi; Hyun-Wook Kim; Seung Baek Han; Il Hwan Kim; Jin Young Bae; Yong Chul Bae; Im Joo Rhyu; Woong Sun; Hyun Kim
Journal:  J Biol Chem       Date:  2012-03-02       Impact factor: 5.157

Review 4.  Is synaptic loss a unique hallmark of Alzheimer's disease?

Authors:  Stephen W Scheff; Janna H Neltner; Peter T Nelson
Journal:  Biochem Pharmacol       Date:  2014-01-09       Impact factor: 5.858

5.  Age-related decline in white matter integrity in a mouse model of tauopathy: an in vivo diffusion tensor magnetic resonance imaging study.

Authors:  Naruhiko Sahara; Pablo D Perez; Wen-Lang Lin; Dennis W Dickson; Yan Ren; Huadong Zeng; Jada Lewis; Marcelo Febo
Journal:  Neurobiol Aging       Date:  2013-12-19       Impact factor: 4.673

6.  Pleiotropic neuropathological and biochemical alterations associated with Myo5a mutation in a rat Model.

Authors:  Kerstin K Landrock; Patti Sullivan; Heidi Martini-Stoica; David S Goldstein; Brett H Graham; Shinya Yamamoto; Hugo J Bellen; Richard A Gibbs; Rui Chen; Marcello D'Amelio; George Stoica
Journal:  Brain Res       Date:  2017-12-05       Impact factor: 3.252

Review 7.  Association of heat-shock proteins in various neurodegenerative disorders: is it a master key to open the therapeutic door?

Authors:  Subhankar Paul; Sailendra Mahanta
Journal:  Mol Cell Biochem       Date:  2013-10-05       Impact factor: 3.396

Review 8.  Immunotherapy targeting pathological tau protein in Alzheimer's disease and related tauopathies.

Authors:  Einar M Sigurdsson
Journal:  J Alzheimers Dis       Date:  2008-10       Impact factor: 4.472

9.  Evidence for gender-specific transcriptional profiles of nigral dopamine neurons in Parkinson disease.

Authors:  Filip Simunovic; Ming Yi; Yulei Wang; Robert Stephens; Kai C Sonntag
Journal:  PLoS One       Date:  2010-01-25       Impact factor: 3.240

10.  Aminopeptidases do not directly degrade tau protein.

Authors:  K Martin Chow; Hanjun Guan; Louis B Hersh
Journal:  Mol Neurodegener       Date:  2010-11-05       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.